phenylethyl alcohol has been researched along with Kidney Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, HI; Durdagi, S; Gulhan, MF; Sahna, E; Salmas, RE; Selamoglu, Z | 1 |
| Davarci, M; Dorum, BA; Gokce, H; Nacar, A; Rifaioglu, MM; Sefil, F | 1 |
| Brinda, BJ; Markowitz, JS | 1 |
| Aksu, O; Altuntaş, A; Bayram, DŞ; Demir, M; Gökçimen, A; Sezer, MT; Uz, E; Yılmaz, HR | 1 |
| Chashmi, NA; Emadi, S; Khastar, H | 1 |
| Aydin, M; Davarci, M; Gökçe, A; Ilhan, S; Oktar, S; Ozkan, OV; Yalçinkaya, FR; Yönden, Z | 1 |
| Colakoglu, N; Kus, I; Ogeturk, M; Ozyurt, H; Pekmez, H; Sonmez, MF | 1 |
| Gomonchareonsiri, S; Thamprasert, K; Wongmekiat, O | 1 |
| Akçam, FZ; Aygün, FO; Ceyhan, BM; Kaya, O; Sütçü, R | 1 |
| Çakır, T; Dulundu, E; Ercan, F; Özkan, E; Şehirli, AÖ; Şener, E; Şener, G; Topaloğlu, Ü | 1 |
| Erdogan, H; Fadillioglu, E; Iraz, M; Songur, A; Ucar, M; Yagmurca, M | 1 |
| Altinyazar, C; Armutcu, F; Gurel, A; Hosnuter, M; Kargi, E; Unalacak, M | 1 |
| Capasso, G; Chiodini, P; Della Ragione, F; Di Gennaro, CI; Galletti, P; Indaco, S; Manna, C; Migliardi, V; Zappia, V | 1 |
| Acet, A; Cigremis, Y; Ozer, MK; Parlakpinar, H; Ucar, M; Vardi, N | 1 |
| Ayata, A; Oktem, F; Olgar, S; Ozguner, F; Uz, E; Uzare, E; Yilmaz, HR | 1 |
| Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
1 review(s) available for phenylethyl alcohol and Kidney Diseases
| Article | Year |
|---|---|
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Child; Half-Life; Humans; Kidney Diseases; Liver Diseases; Morpholines; Phenylethyl Alcohol | 2014 |
15 other study(ies) available for phenylethyl alcohol and Kidney Diseases
| Article | Year |
|---|---|
Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach.
Topics: Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Binding Sites; Caffeic Acids; Glutathione Reductase; Half-Life; Hypertension; Kidney Diseases; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Pollen; Propolis; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley | 2017 |
Protective effects of caffeic acid phenethyl ester on the dose-dependent acute nephrotoxicity with paraquat in a rat model.
Topics: Animals; Antioxidants; Caffeic Acids; Female; Herbicides; Humans; Kidney; Kidney Diseases; Oxidation-Reduction; Paraquat; Phenylethyl Alcohol; Rats; Rats, Wistar | 2015 |
Caffeic acid phenethyl ester protects against amphotericin B induced nephrotoxicity in rat model.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Caffeic Acids; Catalase; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Phenylethyl Alcohol; Rats; Superoxide Dismutase | 2014 |
Protective effects of hydroxytyrosol on gentamicin induced nephrotoxicity in mice.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oxidative Stress; Phenylethyl Alcohol; Sodium; Urination | 2017 |
Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Cyclosporine; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Kidney Diseases; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2009 |
Ameliorative effect of caffeic acid phenethyl ester on histopathological and biochemical changes induced by cigarette smoke in rat kidney.
Topics: Animals; Antioxidants; Blood Chemical Analysis; Caffeic Acids; Dose-Response Relationship, Drug; Inhalation Exposure; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Tobacco Smoke Pollution | 2010 |
Caffeic acid phenethyl ester protects against oxidative stress-related renal dysfunction in rats treated with cyclosporin A.
Topics: Acute Kidney Injury; Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Caffeic Acids; Creatinine; Cyclosporine; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding Behavior; Glutathione; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase | 2011 |
Caffeic acid phenethyl ester modulates gentamicin-induced oxidative nephrotoxicity in kidney of rats.
Topics: Animals; Anti-Bacterial Agents; Caffeic Acids; Creatinine; Female; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Nitric Oxide; Oxidoreductases; Phenylethyl Alcohol; Rats; Rats, Wistar | 2012 |
Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Caffeic Acids; Chemical and Drug Induced Liver Injury; Female; Glutathione; Interleukin-1beta; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha | 2011 |
Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Doxorubicin; Drug Interactions; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nitric Oxide; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Sprague-Dawley | 2004 |
Caffeic acid phenethyl ester improves oxidative organ damage in rat model of thermal trauma.
Topics: Animals; Burns; Caffeic Acids; Disease Models, Animal; Injections, Intraperitoneal; Kidney Diseases; Lung Diseases; Male; Malondialdehyde; Multiple Organ Failure; Oxidoreductases; Phenylethyl Alcohol; Rats; Rats, Wistar; Treatment Outcome | 2004 |
Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells.
Topics: Animals; Antioxidants; Cell Survival; Cells, Cultured; Cyclosporine; Epithelium; Fluoresceins; Glutathione; Kidney Diseases; Kidney Tubules, Proximal; Lipid Peroxides; Phenylethyl Alcohol; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Vitamin E | 2005 |
Myocardial ischemia/reperfusion-induced oxidative renal damage in rats: protection by caffeic acid phenethyl ester (CAPE).
Topics: Animals; Caffeic Acids; Kidney Diseases; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2005 |
Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester.
Topics: Animals; Caffeic Acids; Catalase; Free Radical Scavengers; Glutathione Peroxidase; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Methotrexate; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase | 2006 |
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply | 2007 |